Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
about
Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma CellsApplication and implementation of selective tissue microdissection and proteomic profiling in neurological disease.Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasmaA proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells.Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activityComparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers.Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene.Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokersEx vivo TCR-induced leukocyte gene expression of inflammatory mediators is increased in type 1 diabetic patients but not in overweight childrenClinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancerComparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasIdentification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinomaPeroxiredoxin 4: a multifunctional biomarker worthy of further exploration.Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis.Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry.The changing role of pathology in breast cancer diagnosis and treatment.Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis.Gamma-tocotrienol treatment increased peroxiredoxin-4 expression in HepG2 liver cancer cell lineIdentification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells.Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model systemLEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.Ubiquitin C-terminal hydrolase l1 in tumorigenesisHigh-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.The translation factor eIF5A and human cancer.Gene expression profiling analysis of lung adenocarcinomaInorganic pyrophosphatase defects lead to cell cycle arrest and autophagic cell death through NAD+ depletion in fermenting yeast.Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapyAcute damage by naphthalene triggers expression of the neuroendocrine marker PGP9.5 in airway epithelial cellsProtein profiles associated with survival in lung adenocarcinomaIdentification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.Mass spectrometry-based proteomic profiling of lung cancer.Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model.Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry.
P2860
Q28554921-D4B9E97D-B8A0-462C-BAB5-DC175497DD4DQ30360876-A0299A54-B75F-49B0-AEFE-F2635AD24F4FQ30990299-8FD499FD-C05F-40C2-ADCA-B86A49C7933FQ33195982-FD1A238B-5075-4E7C-8133-B73E524E1F12Q33268625-C703544B-CD23-46C2-921C-97D713677742Q33428572-2D72A0ED-3217-4317-AFD9-DF14690A0B69Q33507899-8CE4AA48-C089-4408-A3AE-239C9C829F66Q33588113-93E67B93-4B35-4975-ACDF-02D1CFCE5D18Q33624786-ABE7C0DD-23E4-4044-8759-0E30BBE3B787Q33672843-546F253A-36BD-41DF-8CCB-106258B61359Q33890039-0472DF7F-92C0-4FF0-85D2-07C7D28E4610Q33933774-512BD42A-4A12-4426-99DC-DE068635BBEBQ34069325-E9737ED4-7CF2-4B17-8C82-D9C52B4F1187Q34075588-7295AA6D-261C-491A-AD9B-04FF6226CBCFQ34111306-865F5019-2593-48C9-9CC5-9DA93BA6CB82Q34448273-A207EEB2-C21F-42D7-AB24-86E3451ACCE8Q34609315-A493682E-71BB-4A32-B316-668FE7D4D60DQ34755599-B1C433A6-5D23-42B2-BF74-ED0B0CE466D4Q35054649-43AA6CBA-4DE6-4D84-9E77-EBB6B09FB0D8Q35082260-8EC330A9-3994-44BE-AAA4-0AF1C01D245CQ35197454-E5BEE674-F27D-4CDA-B156-4C676D8B3E3CQ35206555-2F735AB3-04F6-4F4B-A87F-DA8060A13D2EQ35553475-A3DEBF65-A0D0-4359-9D33-6F57D8796016Q35693161-F1DFCEC5-54EF-4A11-8DCB-DC8C970AE13FQ35895033-A6384CD2-8F15-46BF-8058-0EED51E4354BQ35919069-1E4BD1DE-7FAE-47A4-986F-37D2A6EF804BQ36030339-AFA90A08-B63E-4205-B6D7-23C8A12698BAQ36091119-9ED1587E-22EA-4D23-A684-968B5AB94136Q36288148-91A8F702-B902-4AE5-B6F4-A08B7F98B96DQ36375129-6AA750EC-27D7-4423-8799-B6566BB19827Q36519353-FB498DB1-E239-4D25-BEF8-966475521F1AQ36607728-139C7172-AF4B-4C71-98A4-5F59AC385C2BQ36812488-0A5190BA-2DDD-400A-87A7-CF8F9ADD61C1Q36877600-C215CD78-D31A-4D46-97C9-CBC894294C93Q37038143-AA26D884-83EF-47D9-A8CB-1078EB5DE05DQ37089504-3C2B5DFE-ABD1-44C1-90BF-18EA7B11BEC0Q37092673-2796BF47-2F3E-4BF4-A5D6-E33833208CBBQ37171914-41CD3CE3-D025-4E54-B539-709BF3A590E1Q37185019-E45E1187-A79F-4C63-BF9C-ABB0A8D55774Q37304950-65893590-F971-4CCE-84CA-5801E7977DB7
P2860
Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Proteomic analysis of lung ade ...... sed set of proteins in tumors.
@en
Proteomic analysis of lung ade ...... sed set of proteins in tumors.
@nl
type
label
Proteomic analysis of lung ade ...... sed set of proteins in tumors.
@en
Proteomic analysis of lung ade ...... sed set of proteins in tumors.
@nl
prefLabel
Proteomic analysis of lung ade ...... sed set of proteins in tumors.
@en
Proteomic analysis of lung ade ...... sed set of proteins in tumors.
@nl
P2093
P1476
Proteomic analysis of lung ade ...... ssed set of proteins in tumors
@en
P2093
Chiang-Ching Huang
Dafydd G Thomas
David E Misek
David G Beer
Guoan Chen
Jeremy M G Taylor
Kerby A Shedden
Mark B Orringer
Mark D Iannettoni
Samir M Hanash
P304
P407
P577
2002-07-01T00:00:00Z